Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. S-11c-methyl-l-cysteine
2. S-methylcysteine
3. S-methylcysteine, (dl-cys)-isomer
4. S-methylcysteine, (l-cys)-isomer
5. S-methylcysteine, Hydrochloride, (l-cys)-isomer
1. 1187-84-4
2. S-methylcysteine
3. H-cys(me)-oh
4. S-methyl-cysteine
5. L-cysteine, S-methyl-
6. Cysteine, S-methyl-
7. (r)-2-amino-3-(methylthio)propanoic Acid
8. Alanine, 3-(methylthio)-, L-
9. H-cys(me)-oh.hcl
10. Methylcysteine
11. A34i1h07ym
12. Chembl394875
13. Chebi:45658
14. (2r)-2-amino-3-(methylsulfanyl)propanoic Acid
15. L-methylcysteine
16. Ccris 1972
17. 3-(methylthio)-l-alanine
18. Einecs 214-701-6
19. Nsc 15387
20. Unii-a34i1h07ym
21. (2r)-2-azaniumyl-3-(methylsulfanyl)propanoate
22. (r)-2-ammonio-3-(methylthio)propanoate
23. Nsc-15387
24. S-methyl-l-cys
25. (r)-2-amino-3-(methylmercapto)propionic Acid
26. S-n-methylcysteine
27. Cysteine,s-methyl-
28. D-s-methyl-cysteine
29. Mfcd00002612
30. L-s-methyl-cysteine
31. (2r)-2-amino-3-methylsulfanylpropanoic Acid
32. (-)-s-methyl-l-cysteine
33. S-methylcysteine, L-
34. 3-(methylthio)alanine
35. Schembl110458
36. L-ch3sch2ch(nh2)cooh
37. S-methyl-(r)-cysteine
38. Dtxsid50862579
39. Hy-b2188
40. Zinc3861771
41. Einecs 243-203-1
42. Bdbm50213729
43. S4786
44. S-methyl-l-cysteine, (-)-
45. Akos000275785
46. Am82581
47. Ccg-266126
48. Cs-7653
49. Db02216
50. Gs-3468
51. M0233
52. C22040
53. M-3585
54. A804094
55. J-300343
56. Q27093260
57. 0ddf4489-1bf1-4858-9127-80a71a348ec8
58. S-methyl-l-cysteine, Substrate For Methionine Sulfoxide Reductase A
| Molecular Weight | 135.19 g/mol |
|---|---|
| Molecular Formula | C4H9NO2S |
| XLogP3 | -2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 135.03539970 g/mol |
| Monoisotopic Mass | 135.03539970 g/mol |
| Topological Polar Surface Area | 88.6 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 86.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A S-Methyl-L-Cysteine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of S-Methyl-L-Cysteine, including repackagers and relabelers. The FDA regulates S-Methyl-L-Cysteine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. S-Methyl-L-Cysteine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A S-Methyl-L-Cysteine supplier is an individual or a company that provides S-Methyl-L-Cysteine active pharmaceutical ingredient (API) or S-Methyl-L-Cysteine finished formulations upon request. The S-Methyl-L-Cysteine suppliers may include S-Methyl-L-Cysteine API manufacturers, exporters, distributors and traders.
click here to find a list of S-Methyl-L-Cysteine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The S-Methyl-L-Cysteine Drug Master File in Japan (S-Methyl-L-Cysteine JDMF) empowers S-Methyl-L-Cysteine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the S-Methyl-L-Cysteine JDMF during the approval evaluation for pharmaceutical products. At the time of S-Methyl-L-Cysteine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of S-Methyl-L-Cysteine suppliers with JDMF on PharmaCompass.
S-Methyl-L-Cysteine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of S-Methyl-L-Cysteine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right S-Methyl-L-Cysteine GMP manufacturer or S-Methyl-L-Cysteine GMP API supplier for your needs.
A S-Methyl-L-Cysteine CoA (Certificate of Analysis) is a formal document that attests to S-Methyl-L-Cysteine's compliance with S-Methyl-L-Cysteine specifications and serves as a tool for batch-level quality control.
S-Methyl-L-Cysteine CoA mostly includes findings from lab analyses of a specific batch. For each S-Methyl-L-Cysteine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
S-Methyl-L-Cysteine may be tested according to a variety of international standards, such as European Pharmacopoeia (S-Methyl-L-Cysteine EP), S-Methyl-L-Cysteine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (S-Methyl-L-Cysteine USP).
LOOKING FOR A SUPPLIER?
